PLA2 activity regulates Ca2+ storage-dependent cellular proliferation

Experimental Cell Research

Volumn 244, Issue 1, 1998, Pages 310-318

  Petr, Michael J ^a   Origitano, Thomas C ^a   Wurster, Robert D ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Calcium; PLA2; Proliferation

Indexed keywords

4 BROMOPHENACYL BROMIDE; ARACHIDONIC ACID; CALCIUM ION; DANTROLENE; MEPACRINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; CALCIUM; GROWTH INHIBITOR; ICOSANOID; PHOSPHOLIPASE A;

ARACHIDONIC ACID METABOLISM; ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MENINGIOMA; NERVE CELL CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CALCIUM SIGNALING; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYMOLOGY; MALE; METABOLISM; PHYSIOLOGY;

ASTROCYTOMA; CALCIUM; CALCIUM SIGNALING; CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSANOIDS; ENZYME ACTIVATION; GROWTH INHIBITORS; HUMANS; MALE; MENINGIOMA; PHOSPHOLIPASES A; TUMOR CELLS, CULTURED;

EID: 0032505309     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4181     Document Type: Article

References (43)

1. Fukushima, M. (1992). Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids 47, 1-12.
2. Marnett, L. J. (1992). Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 15, 5575-5589.
3. Smith, W. L. (1989). The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259, 315-324.
4. Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., and Roberts, L. J. (1988). Clinical implications of prostaglandin and thromboxane A2 formation (2). N. Engl. J. Med. 319, 761-767.
5. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A., and Serhan, C. N. (1987). Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237, 1171-1176.
6. Chiabrando, C., Broggini, M., Castagnoli, M. N., Donelli, M. G., Noseda, A., Visintainer, M., Garattini, S., and Fanelli, R. (1985). Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth. Cancer Res. 45, 3605-3608.
7. Chiabrando, C., Broggini, M., Castelli, M. G., Cozzi, E., Castagnoli, M. N., Donelli, M. G., Garattini, S., Giavazzi, R., and Fanelli, R. (1987). Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: Effects of a thromboxane synthetase inhibitor. Cancer Res. 47, 988-991.
8. Bennett, A., Charlier, E. M., McDonald, A. M., Simpson, J. S., Stamford, I. F., and Zebro, T. (1977). Prostaglandins and breast cancer. Lancet 2, 624-626.
9. Rolland, P. H., Martin, P. M., Jacquemier, J., Rolland, A. M., and Toga, M. (1980). Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer. Inst. 64, 1061-1070.
10. Watson, J., and Chuah, S. Y. (1985). Prostaglandins, steroids and human mammary cancer. Eur. J. Cancer Clin. Oncol. 21, 1051-1055.
11. De Asua, L. J., Clingan, D., and Rudland, P. S. (1975). Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha. Proc. Natl. Acad. Sci. USA72, 2724-2728.
12. Karmali, R. A., Horrobin, D. F., Menezes, J., and Patel, P. (1979). The relationship between concentrations of prostaglandin A1, E1, E2 and E2alpha and rates of cell proliferation. Pharmacol. Res. Commun. 11, 69-75.
13. Keyaki, A., Handa, H., Yamashita, J., Tokuriki, Y., Otsuka, S., Yamasaki, T., and Gi, H. (1984). Growth-inhibitory effect of prostaglandin D2 on mouse glioma cells. J. Neurosurg. 61, 912-917.
14. Moran, R. E., and Straus, M. J. (1983). Labeling indices of human lung cancer. Correlation with histologic type and survival. Anal. Quant. Cytol. 5, 250-254.
15. Dethlefsen, S. M., Shepro, D., and D'Amore, P. A. (1994). Arachidonic acid metabolites in bFGF, PDGF, and serum-stimulated vascular cell growth. Exp. Cell Res. 212, 262-273.
16. Di Marzo, V., Galadari, S. H., Tippins, J. R., and Morris, H. R. (1991). Interactions between second messengers: Cyclic AMP and phospholipase A2 and phospholipase C metabolites. Life Sci. 49, 247-259.
17. Liscovitch, M. (1991). Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci. 17, 393-399.
18. Breton, M., and Colard, O. (1991). Protein kinase C promotes arachidonate mobilization through enhancement of CoA-independent transacylase activity in platelets. Biochem. J. 280, 93-98.
19. Chao, W., Liu, H., Hanahan, D. J., and Olson, M. S. (1992). Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways. J. Biol. Chem. 267, 6725-6735.
20. Thomson, F. J., and Mitchell, R. (1993). Differential involvement of phospholipase A2 in phorbol ester-induced luteinizing hormone and growth hormone release from rat anterior pituitary tissue. Mol. Cell. Endocrinol. 95, 75-83.
21. Burch, R. M. (1989). G protein regulation of Phospholipase A2. Mol. Neurobiol. 3, 155-171.
22. Bruner, G., and Murphy, S. (1993). Purinergic P2Y receptors on astrocytes are directly coupled to phospholipase A2. Glia 7, 219-224.
23. Asaoka, Y., Nakamura, S., Yoshida, K., and Nishizuka, Y. (1992). Protein kinase C, calcium and phospholipid degradation. Trends Biochem. Sci. 17, 414-417.
24. Ponten, J., and Macintyre, E. H. (1968). Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74, 465-486.
25. Jones, T. R., Bigner, S. H., Schold, S. C., Jr., Eng, L. F., and Bigner, D. D. (1981). Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression. Am. J. Pathol. 105, 316-327.
26. Lee, Y. S., Sayeed, M. M., and Wurster, R. D. (1994). Inhibition of cell growth and intracellular Ca2+ mobilization in human brain tumor cells by Ca2+ channel antagonists. Mol. Chem. Neuropathol. 22, 81-95.
27. Jensen, R. L., Origitano, T. C., Lee, Y. S., Weber, M., and Wurster, R. D. (1995). In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36, 365-373.
28. Volterra, A., Trotti, D., Bezzi, P., Civenni, G., and Racagni, G. (1995). [Ca2+] modulates the ratio between cycloxygenase and lipoxygenase metabolism of arachidonic acid in homogenates of hippocampal astroglial cultures. Neurosci. Lett. 183, 160-163.
29. Powell, W. S. (1985). Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases. Anal. Biochem. 148, 59-69.
30. Kao, J. P. (1994). Practical aspects of measuring [Ca2+] with fluorescent indicators. Methods Cell Biol. 40, 155-181.
31. Byron, K., and Taylor, C. W. (1995). Vasopressin stimulation of Ca2+ mobilization, two bivalent cation entry pathways and Ca2+ efflux in A7r5 rat smooth muscle cells. J. Physiol. (London) 485, 455-468.
32. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
33. Purkiss, J. R., Nahorski, S. R., and Willars, G. B. (1995). Mobilization of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores supports bradykinin- and muscarinic-evoked release of [3H] noradrenaline from SH-SY5Y cells. J. Neurochem. 64, 1175-1182.
34. Demaurex, N., Lew, D. P., and Krause, K. H. (1992). Cyclopiazonic acid depletes intracellular Ca2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J. Biol. Chem. 267, 2318-2324.
35. Petr, M. J., and Wurster, R. D. (1997). Determination of in situ dissociation constant for Fura-2 and quantitation of background fluorescence in astrocyte cell line U373-MG. Cell Calcium 21, 233-240.
36. Maruyama, Y. (1993). Control of inositol polyphosphate-mediated calcium mobilization by arachidonic acid in pancreatic acinar cells of rats. J. Physiol. (London) 463, 729-746.
37. Won, J. G., and Orth, D. N. (1994). Role of lipoxygenase metabolites of arachidonic acid in the regulation of adrenocorticotropin secretion by perifused rat anterior pituitary cells. Endocrinology 135, 1496-1503.
38. Villereal, M. L., and Byron, K. L. (1992). Calcium signals in growth factor signal transduction. Rev. Physiol. Biochem. Pharmacol. 119, 67-121.
39. Alford, R. H. (1970). Metal cation requirements for phytohemagglutinin-induced transformation of human peripheral blood lymphocytes. J. Immunol. 104, 698-703.
40. Whitney, R. B., and Sutherland, R. M. (1972). Requirement for calcium ions in lymphocyte transformation stimulated by phytohemagglutinin. J. Cell Physiol. 80, 329-337.
41. Jensen, R. L., Origitano, T. C., Lee, Y. S., Weber, M., and Wurster, R. D. (1995). In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36, 365-73.
42. Ghosh, T. K., Bian, J. H., Short, A. D., Rybak, S. L., and Gill, D. L. (1991). Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J. Biol. Chem. 266, 24690-24697.
43. Graber, M. N., Alfonso, A., and Gill, D. L. (1996). Ca2+ pools and cell growth: arachidonic acid induces recovery of cells growth-arrested by Ca2+ pool depletion. J. Biol. Chem. 271, 883-888.